Episode 187: Breakthroughs Take Time: Looking at the Future of Parkinson’s Research
There is still much to learn about Parkinson’s disease (PD), and it remains an ongoing challenge for scientists and researchers. The Parkinson’s Foundation recognizes the importance of supporting new and innovative ideas to advance research toward a cure.
Research takes time- from a conceptual idea to early laboratory work, with the hope of eventually progressing to clinical stages and, ultimately, a breakthrough. PD GENEration: Powered by the Parkinson’s Foundation is a global research initiative that offers genetic testing and counseling to people with Parkinson’s. The goal is to use the genetic data collected to accelerate current and future clinical trials aimed at developing better, more personalized treatments for Parkinson’s.
In this episode, we speak with Connor Courtney, Associate Director of Research Programs at the Parkinson’s Foundation. He takes a deep dive into how basic science lays the groundwork for future research and highlights the importance of supporting young scientists throughout their career in Parkinson’s research. We later invite Maggie Caulfield, Director of Research Programs, who shares recent key insights from the PD GENEration study and discusses current challenges in Parkinson’s research. Together, Maggie and Courtney emphasize the vital role individuals can play by learning more about and participating in research.
Released: December 30, 2025
We want to thank this episode’s podcast sponsor, BlueRock Therapeutics, for supporting our mission.
Want more?
Don't forget to subscribe! There are many ways to listen: Apple Podcasts, TuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)
For all of our Substantial Matters podcast episodes, visit Parkinson.org/Podcast.
Related Materials
Related Blog Posts
Celebrating 12 Milestones that Defined 2025
From Parkinson’s Foundation Research Center to Powerhouse: How Yale Became a Leader in Parkinson’s Science